These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30173851)

  • 1. The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines.
    Mullish BH; Quraishi MN; Segal JP; McCune VL; Baxter M; Marsden GL; Moore D; Colville A; Bhala N; Iqbal TH; Settle C; Kontkowski G; Hart AL; Hawkey PM; Williams HR; Goldenberg SD
    J Hosp Infect; 2018 Sep; 100 Suppl 1():S1-S31. PubMed ID: 30173851
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of faecal microbiota transplant as treatment for recurrent or refractory
    Mullish BH; Quraishi MN; Segal JP; McCune VL; Baxter M; Marsden GL; Moore DJ; Colville A; Bhala N; Iqbal TH; Settle C; Kontkowski G; Hart AL; Hawkey PM; Goldenberg SD; Williams HRT
    Gut; 2018 Nov; 67(11):1920-1941. PubMed ID: 30154172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridioides difficile infection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines.
    Mullish BH; Merrick B; Quraishi MN; Bak A; Green CA; Moore DJ; Porter RJ; Elumogo NT; Segal JP; Sharma N; Marsh B; Kontkowski G; Manzoor SE; Hart AL; Settle C; Keller JJ; Hawkey P; Iqbal TH; Goldenberg SD; Williams HRT
    J Hosp Infect; 2024 Jun; 148():189-219. PubMed ID: 38609760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of faecal microbiota transplant as treatment for recurrent or refractory
    Mullish BH; Merrick B; Quraishi MN; Bak A; Green CA; Moore DJ; Porter RJ; Elumogo NT; Segal JP; Sharma N; Marsh B; Kontkowski G; Manzoor SE; Hart AL; Settle C; Keller JJ; Hawkey P; Iqbal TH; Goldenberg SD; Williams HRT
    Gut; 2024 Jun; 73(7):1052-1075. PubMed ID: 38609165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction to the joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) faecal microbiota transplant guidelines.
    Mullish BH; Quraishi MN; Segal JP; Williams HRT; Goldenberg SD
    J Hosp Infect; 2018 Oct; 100(2):130-132. PubMed ID: 30241676
    [No Abstract]   [Full Text] [Related]  

  • 6. Faecal microbiota transplantation in recurrent Clostridium difficile infection: Recommendations from the French Group of Faecal microbiota Transplantation.
    Sokol H; Galperine T; Kapel N; Bourlioux P; Seksik P; Barbut F; Scanzi J; Chast F; Batista R; Joly F; Joly AC; Collignon A; Guery B; Beaugerie L;
    Dig Liver Dis; 2016 Mar; 48(3):242-7. PubMed ID: 26433619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recurrent Clostridium difficile infection treated with faecal microbiota transplantation].
    Fløe A; Leutscher P
    Ugeskr Laeger; 2014 Feb; 176(4):. PubMed ID: 25095866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection-single versus multiple infusions.
    Ianiro G; Masucci L; Quaranta G; Simonelli C; Lopetuso LR; Sanguinetti M; Gasbarrini A; Cammarota G
    Aliment Pharmacol Ther; 2018 Jul; 48(2):152-159. PubMed ID: 29851107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal Microbiota Transplantation for Primary Clostridium difficile Infection.
    Juul FE; Garborg K; Bretthauer M; Skudal H; Øines MN; Wiig H; Rose Ø; Seip B; Lamont JT; Midtvedt T; Valeur J; Kalager M; Holme Ø; Helsingen L; Løberg M; Adami HO
    N Engl J Med; 2018 Jun; 378(26):2535-2536. PubMed ID: 29860912
    [No Abstract]   [Full Text] [Related]  

  • 10. [Fecal microbiota transplant in the treatment of recurrent Clostridium difficile infection: A case report].
    Haemers I; Delvallée M
    Rev Med Brux; 2016; 37(3):174-177. PubMed ID: 28525191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term durability and safety of fecal microbiota transplantation for recurrent or refractory Clostridioides difficile infection with or without antibiotic exposure.
    Lee CH; Chai J; Hammond K; Jeon SR; Patel Y; Goldeh C; Kim P
    Eur J Clin Microbiol Infect Dis; 2019 Sep; 38(9):1731-1735. PubMed ID: 31165961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clostridium difficile Infection and Fecal Microbiota Transplant.
    Liubakka A; Vaughn BP
    AACN Adv Crit Care; 2016 Jul; 27(3):324-337. PubMed ID: 27959316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review with meta-analysis: long-term outcomes of faecal microbiota transplantation for Clostridium difficile infection.
    Li YT; Cai HF; Wang ZH; Xu J; Fang JY
    Aliment Pharmacol Ther; 2016 Feb; 43(4):445-57. PubMed ID: 26662643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory Testing of Donors and Stool Samples for Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection.
    Woodworth MH; Neish EM; Miller NS; Dhere T; Burd EM; Carpentieri C; Sitchenko KL; Kraft CS
    J Clin Microbiol; 2017 Apr; 55(4):1002-1010. PubMed ID: 28077694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Romanian National Guideline on Translating Fecal Microbiota Transplantation Applications related to Clostridioides difficile Infections into the Local Clinical Practice.
    Gilca-Blanariu GE; Stefanescu G; Girleanu I; Iqbal T; Segal J; Mullish B; Quraishi MN; Keller J; Molnar T; Megraud F; Dumitrascu D; Manuc M; Iancu LS; Marica C; Gheorghe C; Manzoor S; Trifan A
    J Gastrointestin Liver Dis; 2021 Mar; 30(1):147-163. PubMed ID: 33723543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addendum for: Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection and Other Conditions in Children: A Joint Position Paper From the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition.
    J Pediatr Gastroenterol Nutr; 2020 Mar; 70(3):404. PubMed ID: 31880660
    [No Abstract]   [Full Text] [Related]  

  • 17. Faecal microbiota transplantation for Clostridium difficile infection in the United Kingdom.
    Porter RJ; Fogg C
    Clin Microbiol Infect; 2015 Jun; 21(6):578-82. PubMed ID: 25677629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal microbiota transplantation in recurrent Clostridium difficile infection in a patient with concomitant inflammatory bowel disease.
    Gravito-Soares M; Gravito-Soares E; Portela F; Ferreira M; Sofia C
    Rev Esp Enferm Dig; 2017 Jun; 109(6):473-476. PubMed ID: 28506071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal microbiota transplant to treat recurrent Clostridium difficile infections.
    Boyle ML; Ruth-Sahd LA; Zhou Z
    Crit Care Nurse; 2015 Apr; 35(2):51-64; quiz 65. PubMed ID: 25834008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Faecal Microbiota Transplantation for Clostridium Difficile - a local perspective.
    Diamond C; McNeilly T
    Ulster Med J; 2017 May; 86(2):108-110. PubMed ID: 29535482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.